Table 2.
Change from baseline (%) in oxidative stress and inflammation markers before and after salsalate treatment
Before | After | |
---|---|---|
Saturated fat ingestion (n = 8) | ||
ROS generation | 89 ± 13 | 42 ± 13a |
p47phox mRNA content | 29 ± 5 | 11 ± 2a |
p105 mRNA content | 30 ± 3 | 12 ± 3a |
p65 mRNA content | 28 ± 3 | 11 ± 2a |
TNFα mRNA content | 18 ± 4 | 5 ± 2a |
TNFα secretion | 24 ± 12 | 3 ± 6a |
Plasma TNFα | 19 ± 4 | 7 ± 1a |
Hyperglycemic infusion (n = 5) | ||
ROS generation | 56 ± 9 | 23 ± 11b |
p47phox mRNA content | 27 ± 5 | 10 ± 2b |
p105 mRNA content | 28 ± 4 | 12 ± 6b |
p65 mRNA content | 23 ± 5 | 8 ± 4b |
TNFα mRNA content | 36 ± 6 | 13 ± 3b |
TNFα secretion | 26 ± 8 | 4 ± 7b |
Plasma TNFα | 34 ± 7 | 16 ± 4b |
Values are expressed as means ± SE. mRNA, messenger ribonucleic acid; ROS, reactive oxygen species; TNFα, tumor necrosis factor-α. Significantly decreased after salsalate treatment (paired Student’s t test),
P < 0.02;
P < 0.03.